Biotech

All Articles

Otsuka spends $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Drug has actually picked up Boston-based Jnana Rehabs for $800 thousand so the Oriental biot...

FibroGen lays off 75% of US workers as asset fails 2 more tests

.FibroGen is actually substantially reorganizing its own service, laying off 75% of its own USA pers...

Tracon unwind full weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has actually determined to relax operations weeks after an injectable immune...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on failed epilepsy medication, proclaims FDA operate

.Our experts actually understand that Takeda is actually wishing to discover a road to the FDA for e...

VBI Vaccinations files for bankruptcy, finds asset purchase

.Immunology biotech VBI Injections is veering hazardously close to the defining moment, along with p...

Celldex anti-cKIT antitoxin decrease colonies in yet another period 2 research study

.It's hard to muscle mass in on an area as reasonable as immunology, yet Celldex Rehabs strongly bel...

Boehringer provides to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapies and a preclinical ...

Ventyx's last hope for inflamed med sides in Crohn's failing

.Ventyx Biosciences' Crohn's illness medication performed certainly not aid individuals attain remis...

Cognition's period 2 radiate information stain Alzheimer's possibility

.Knowledge Therapies' stage 2 SHINE trial has taken a few of the appeal off the Alzheimer's illness ...